Nasogastric Tube Market is Expected to Reach US$ 660.5 Million by 2032: IMARC Group
The global nasogastric tube market size reached US$ 437.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 660.5 Million by 2032, exhibiting a growth rate (CAGR) of 4.69% during 2024-2032.

Summary: 

  • The global nasogastric tube market size reached USD 437.3 Million in 2023.
  • The market is expected to reach USD 660.5 Million by 2032, exhibiting a growth rate (CAGR) of 4.69% during 2024-2032.
  • North America leads the market, accounting for the largest nasogastric tube market share.
  • Based on the product, the market has been segmented into levin tube, salem sump tube, and others.
  • Adult holds the largest share in the nasogastric tube industry.
  • Esophageal cancer remains a dominant segment in the market due to its frequent need for nasogastric feeding to manage nutrition in patients with blocked swallowing pathways.
  • Hospitals and nursing homes represent the leading end use segment.
  • The expanding use of nasogastric tubes in home healthcare is a primary driver of the nasogastric tube market.
  • The nasogastric tube market growth and forecast highlight a significant rise due to rising adoption of silicone and polyurethane nasogastric tubes.

Industry Trends and Drivers: 

  • Growing Use of Nasogastric Tubes in Home Healthcare:

The industry is witnessing several nasogastric tube market trends including significant growth in the home healthcare sector as more patients opt for at-home treatment to avoid extended hospital stays. Advances in nasogastric tube design have made it easier for non-professional caregivers to assist patients with feeding and medication administration at home, enabling more independence for patients and families. This shift is especially relevant for those with chronic conditions, such as neurological disorders or cancer, where prolonged tube feeding may be necessary. Telemedicine and remote monitoring technologies are also facilitating home-based care by allowing healthcare providers to oversee tube placements and monitor patient progress remotely. The growing elderly population further contributes to this trend, as aging patients often require nutritional support at home. The expanding availability of home healthcare services and the convenience of in-home nasogastric feeding options are expected to continue driving demand, reshaping the nasogastric tube market to include more patient-centered, at-home care solutions.

  • Increased Adoption of Silicone and Polyurethane Nasogastric Tubes:

The nasogastric tube market share is expanding due to the increased preference of silicone and polyurethane materials, which offer greater patient comfort and durability compared to traditional PVC tubes. Silicone and polyurethane tubes are softer and more flexible, reducing the risk of irritation and discomfort for long-term users. This is particularly important for patients who require extended nasogastric feeding, such as those with chronic illnesses or those undergoing cancer treatments. Additionally, these materials are compatible with a wider range of nutrients and medications, improving overall treatment flexibility. Many healthcare providers prefer silicone and polyurethane tubes as they are less likely to cause blockages, an essential feature for reducing the frequency of tube replacement and associated complications. As a result, manufacturers are increasingly focusing on silicone and polyurethane-based nasogastric tubes, and healthcare facilities are integrating these materials into their protocols, driven by the goal of enhancing patient comfort and treatment outcomes. This trend is expected to further enhance the nasogastric tube demand in the industry.

  • Increasing Demand for Pediatric Nasogastric Tubes:

The demand for pediatric nasogastric tubes is rising as awareness about nutritional support needs in neonatal and pediatric care increases. Nasogastric feeding is a vital solution for infants and young children who cannot feed orally, particularly those with congenital anomalies, prematurity, or severe illnesses requiring long-term nutrition. Manufacturers are responding by designing pediatric-specific nasogastric tubes that are smaller, softer, and more flexible, minimizing discomfort and ensuring safer, age-appropriate care. Pediatric nasogastric tubes also need to be radiopaque and biocompatible to ensure safety and visibility during insertion and monitoring. The rise of pediatric care facilities and specialized neonatal care centers globally supports this demand, as they require reliable and safe feeding solutions for young patients. Additionally, initiatives promoting awareness around malnutrition in infants and children in developing regions have led to an increased focus on nasogastric feeding as a viable solution. These market trends are responsible for the continued growth in the nasogastric tube market size.

Request Sample For PDF Report: https://www.imarcgroup.com/nasogastric-tube-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

  • Levin Tube
  • Salem Sump Tube
  • Others

Based on the product, the market has been segmented into levin tube, salem sump tube, and others.

Breakup by Patient Type:

  • Adult
  • Pediatric
  • Geriatric

Adult dominates the market due to the higher prevalence of conditions requiring nasogastric tube placement among adults.

Breakup by Indication:

  • Stomach Cancer
  • Esophageal Cancer
  • IBD (Inflammatory Bowel Disease)
  • Chronic Kidney Disease
  • Dysphagia
  • Others

Esophageal cancer represents the majority of shares as it frequently necessitates nasogastric feeding for nutrition management in patients with obstructed swallowing pathways.

Breakup by End Use:

  • Hospitals and Nursing Homes
  • Home Care

Hospitals and nursing homes hold the majority of shares due to their high patient volume and need for continuous, managed care for tube-fed individuals.

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America holds the leading position owing to a large market for nasogastric tube driven by advanced healthcare infrastructure, high awareness, and significant investment in medical devices.

Top Nasogastric Tube Market Leaders:

  • Angiplast Pvt. Ltd.
  • Becton, Dickinson and Company
  • Bicakcilar Medical Devices
  • Cardinal Health Inc.
  • Guangdong Baihe Medical Technology Co. Ltd.
  • Hangzhou Formed Medical Devices Co.Ltd.
  • Poly Medicure Limited
  • QMD
  • Securmed SpA (Delta Med)
  • Vygon

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Nasogastric Tube Market is Expected to Reach US$ 660.5 Million by 2032: IMARC Group
disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations